Cite
Barsanti PA, Aversa RJ, Jin X, et al. Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS Med Chem Lett. 2014;6(1):37-41doi: 10.1021/ml500353p.
Barsanti, P. A., Aversa, R. J., Jin, X., Pan, Y., Lu, Y., Elling, R., Jain, R., Knapp, M., Lan, J., Lin, X., Rudewicz, P., Sim, J., Taricani, L., Thomas, G., Xiao, L., & Yue, Q. (2015). Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS medicinal chemistry letters, 6(1), 37-41. https://doi.org/10.1021/ml500353p
Barsanti, Paul A, et al. "Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors." ACS medicinal chemistry letters vol. 6,1 (2015): 37-41. doi: https://doi.org/10.1021/ml500353p
Barsanti PA, Aversa RJ, Jin X, Pan Y, Lu Y, Elling R, Jain R, Knapp M, Lan J, Lin X, Rudewicz P, Sim J, Taricani L, Thomas G, Xiao L, Yue Q. Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. ACS Med Chem Lett. 2014 Nov 20;6(1):37-41. doi: 10.1021/ml500353p. eCollection 2015 Jan 08. PMID: 25589927; PMCID: PMC4291715.
Copy
Download .nbib